Novel aminobenzimidazoles as selective MCH-R1 antagonists for the treatment of metabolic diseases
Authors:
- T.K. SasikumarTST.K. Sasikumar
- Li QiangLQLi Qiang
- Duane A. BurnettDBDuane A. Burnett
- William J. GreenleeWGWilliam J. Greenlee
- Brian E. HawesBHBrian E. Hawes
- Timothy J. KowalskiTKTimothy J. Kowalski
- Kim O’nEillKOKim O’nEill
- Brian D. SparBSBrian D. Spar
- Blair WeigBWBlair Weig
- 1 October 2006
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (20) , 5427-5431
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Identification of ortho-amino benzamides and nicotinamides as MCHr1 antagonistsBioorganic & Medicinal Chemistry Letters, 2005
- Synthesis and evaluation of 2-amino-8-alkoxy quinolines as MCHr1 antagonists. Part 1Bioorganic & Medicinal Chemistry Letters, 2004
- Recent developments in the discovery of melanin-concentrating hormone antagonists: novel antiobesity agentsExpert Opinion on Therapeutic Patents, 2004
- Acute and chronic administration of melanin-concentrating hormone enhances food intake and body weight in Wistar and Sprague–Dawley ratsInternational Journal of Obesity, 2002
- Rats lighten up with MCH antagonistNature Medicine, 2002
- T-226296: a novel, orally active and selective melanin-concentrating hormone receptor antagonistEuropean Journal of Pharmacology, 2002
- Melanin-concentrating Hormone Receptor: An Orphan Receptor Fits the KeyTrends in Endocrinology & Metabolism, 2000
- Central nervous system control of food intakeNature, 2000
- Mice lacking melanin-concentrating hormone are hypophagic and leanNature, 1998
- A role for melanin-concentrating hormone in the central regulation of feeding behaviourNature, 1996